Automated description from the Alliance of Genome Resources (Release 8.0.0)
Predicted to enable kinase binding activity. Predicted to be involved in negative regulation of NF-kappaB transcription factor activity and negative regulation of toll-like receptor signaling pathway. Predicted to be active in cytoplasm. Is expressed in several structures, including genitourinary system; inner ear; liver; lung; and nervous system. Orthologous to human LRRC14 (leucine rich repeat containing 14).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.